Back to mobile site

BofA/Merrill Lynch Cuts MannKind (MNKD) to Underperform Following FDA Decision

January 20, 2011 9:43 AM EST Send to a Friend
BofA/Merrill Lynch downgraded MannKind (NASDAQ: MNKD) to Underperform following the decision from the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login